IFF—a leading global player in the health and wellbeing industry—today reveals it has achieved the successful production of a strict anaerobic ‘next generation’ probiotic strain at industrial scale. The remarkable milestone demonstrates IFF’s unique capabilities […]
Pragma Bio, the technology-enabled platform for drug discovery formerly known as VastBiome, announced it has raised an additional $10 million in equity to continue its development of proprietary methods in genomic sequencing, artificial intelligence and […]
Not all probiotics are created equal. In a new study, researchers found that certain enzymes within a class known as bile salt hydrolases (BSHs) can restrict Clostridioides difficile (C. diff.) colonization by both altering existing bile acids and […]
Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of “bacterial suicide squad” that targets tumors, attracting the host’s own immune cells to the cancer to destroy it. […]
Basel, Switzerland, and Hørsholm, Denmark, March 13th 2023 – Bacthera, a specialized contract development and manufacturing organization (CDMO), announced today that it has acquired a cGMP manufacturing site in León (ES) from 4D Pharma. Acquiring […]
When parts of the liver are removed, the body can replace the missing tissue. A team of researchers at the Technical University of Munich (TUM) has now discovered that the success of this process depends […]
As antibacterial resistance continues to render obsolete the use of some antibiotics, some have turned to bacteria-killing viruses to treat acute infections as well as some chronic illnesses. Graham Hatfull, the Eberly Family Professor of […]
Published in the journal Gut, the study by scientists at the CHUM Research Centre (CRCHUM) in Montreal identified two bacterial strains that directly affect whether or not anastomotic leakage, more commonly known as intestinal leakage, […]
Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, announced today their plan to open a laboratory in the heart of Boston, Massachusetts, later […]
L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in the development and production of […]
A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage […]